Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Epilepsy and Seizures: Overview

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Frequency Band Personalization for Seizure Network Analysis in Multifocal Patients.

International journal of neural systems·2026

Same author

Human proteome distribution atlas for tissue-specific plasma proteome dynamics.

Cell·2025

Same author

Coxsackie B virus myositis in a healthy young man with mumps co-infection.

IDCases·2023

Same author

Effects of psychiatric comorbidities in persons with epilepsy on recurrent emergency department visits.

Epilepsy & behavior : E&B·2022

Same author

A self-sustaining layer of early-life-origin B cells drives steady-state IgA responses in the adult gut.

Immunity·2022

Same author

Lentiviral Barcode Labeling and Transplantation of Fetal Liver Hematopoietic Stem and Progenitor Cells.

Bio-protocol·2021

Same journal

Current Practices in the Treatment of Dual Diagnosis: Insights from a Nationwide Survey of Italian Psychiatrists on Pharmacological and Nonpharmacological Approaches, Challenges, and Limitations.

Journal of dual diagnosis·2026

Same journal

Suicide-Related Mortality Among Individuals with Mental and Behavioral Disorders Due to Psychoactive Substance Use: A 25-Year U.S. Nationwide Analysis (1999-2023).

Journal of dual diagnosis·2026

Same journal

Inconsistent Self-Reports of Lifetime Suicide Attempts During Residential Treatment for Opioid Use Disorder.

Journal of dual diagnosis·2026

Same journal

Differences in Mental Health, Risk Behaviors, and Social Determinants Among Anabolic-Androgenic Steroid Consumers With and Without Co-occurring Methamphetamine Use in Australia.

Journal of dual diagnosis·2026

Same journal

Dopamine Receptor Modulation in Co-Occurring Disorders: Potential of Cariprazine and D3 Receptor Activity.

Journal of dual diagnosis·2026

Same journal

The Role of Emotional Avoidance in the Relation Between Posttraumatic Stress Disorder Symptoms and Alcohol Use and Related Harm Amongst Asian American Adults.

Journal of dual diagnosis·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 21, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

Cannabis and Epilepsy.

Alexander Doyle¹, Jay Harvey¹

¹Department of Neurology, UTSW Epilepsy Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Journal of Dual Diagnosis

|August 7, 2019

Summary

This summary is machine-generated.

Cannabidiol (CBD) shows promise for treating severe epilepsy. Historical and recent research supports its use in rare, difficult-to-treat epilepsy syndromes, offering a novel therapeutic avenue.

Keywords:

Epilepsy cannabidiol cannabis marijuana

More Related Videos

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Related Experiment Videos

Last Updated: Jan 21, 2026

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Employing Aeroponic Systems for the Clonal Propagation of Cannabis

Published on: December 1, 2021

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass

Published on: May 27, 2022

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study

Published on: August 18, 2020

Area of Science:

Neurology
Pharmacology
Medical History

Background:

Cannabidiol (CBD) is a compound derived from marijuana, which has a long history of medicinal use.
Recent scientific interest focuses on CBD's potential therapeutic applications, particularly in neurological disorders.
Refractory epilepsy, characterized by seizures resistant to conventional treatments, presents a significant unmet medical need.

Purpose of the Study:

To review the historical and contemporary scientific literature on the use of cannabinoids, specifically cannabidiol, for epilepsy treatment.
To evaluate the evidence supporting cannabidiol as a treatment for refractory epilepsy.

Main Methods:

A comprehensive literature search was conducted using the PubMed database.
The review focused on studies examining the history and scientific basis of cannabinoid use in epilepsy management.

Main Results:

Historical evidence indicates the long-standing use of marijuana for medical purposes, including seizure management.
Contemporary research and clinical investigations highlight the potential of cannabidiol in treating specific epilepsy syndromes.
Scientific developments support the efficacy of cannabidiol in rare and severe forms of epilepsy.

Conclusions:

Both historical context and recent scientific findings validate the investigation of cannabidiol for epilepsy treatment.
Cannabidiol represents a promising therapeutic option for patients with rare and severe epilepsy syndromes unresponsive to standard therapies.